BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard T.H. Chan School of Public Health - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Harvard T.H. Chan School of Public Health
X-ORIGINAL-URL:https://hsph.harvard.edu
X-WR-CALDESC:Events for Harvard T.H. Chan School of Public Health
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260513T130000
DTEND;TZID=America/New_York:20260513T140000
DTSTAMP:20260410T141359
CREATED:20260325T145914Z
LAST-MODIFIED:20260410T053554Z
UID:111360005917-1778677200-1778680800@hsph.harvard.edu
SUMMARY:Discovery to intervention: The Healthy Life Trajectories Initiative with Stephen G. Matthews\, PhD\, FCAHS
DESCRIPTION:Home / Events\n\n\n\n\n\n\nThe Global Flourishing Study\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Type \n\n\n\n\n\n\n\nEvent Type \n\n\n\n	From Around the School\, Lectures/Seminars/Forums\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPlease join the Harvard Chan NIEHS Center for Environmental Health and the Department of Environmental Health for a talk by Stephen G. Matthews\, PhD\, FCAHS\, Canada Research Chair in Early Development and Health and Professor of Physiology\, Ob-Gyn and Medicine at the University of Toronto. Dr. Matthews will discuss “Discovery to intervention: The Healthy Life Trajectories Initiative.” \n\n\n\nThis event will be held in person (HSPH Bldg. 1\, 1302) and via Zoom. Lunch and refreshments provided! Register here \n\n\n\nTrainee meeting for students and postdocs immediately following the seminar\, 2-3 pm\, in 1306A! Come in-person to discuss research interests\, career plans\, and funding opportunities. RSVP here! \n\n\n\nAbstract\n\n\n\nIt is well established that the environment during pregnancy can have a long-term impact on cardiometabolic and neurodevelopmental outcomes in offspring and increase risk of non-communicable diseases (NCDs) in later life. There is growing evidence from preclinical studies and some clinical studies that the preconception period in both females and males and the early pregnancy phase are periods of high sensitivity to environmental perturbation. The Healthy Life Trajectories Initiative (HeLTI) was developed to translate new knowledge in the area of developmental origins of health and disease (DOHaD) and improve the health of mothers\, infants and children. The HeLTI consortium includes harmonized trials in Canada\, China\, India and South Africa designed to evaluate the impact of an integrated evidence-based intervention package\, delivered through the preconception\, pregnancy and postnatal period on\, 1) reducing adiposity and obesity\, and improving neurodevelopmental and cardiometabolic development in infants and children to 5-years of age and\, 2) improving maternal health and pregnancy outcomes. All trials have completed recruitment and combine harmonized data and biospecimen collection. The HeLTI-India trial will be described in detail. Findings from the HeLTI studies will have profound implications for public health policy but will also allow determination of the mechanisms that underlie intergenerational transmission. HeLTI is funded by the Canadian Institutes for Health Research and International funding agencies (India\, China and South Africa) and is partnered with WHO. \n\n\n\nAbout the speaker\n\n\n\nStephen Matthews\, PhD\, FCAHS\, is Canada Research Chair in Early Development and Health\, Professor of Physiology\, Ob-Gyn and Medicine at the University of Toronto and a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute\, Sinai Health. He served as Chair of the Department of Physiology (UofT; 2007-2014). He is currently Director of Research at the Alliance for Human Development\, LTRI\, and Director of the Ontario Birth Study. Matthews is also the Canadian lead PI of the CIHR/DBT-funded Healthy Life Trajectories (HeLTI) trial in India. \n\n\n\nHis fundamental research program is determining mechanisms by which early interventions and exposures can impact long-term neurologic and endocrine function in offspring across multiple generations. With a focus on epigenetics\, his research team is determining the molecular mechanisms by which this occurs. In a parallel program\, his group is investigating drug and hormone transport mechanisms in the placenta and fetal brain\, with a focus on developing novel treatments to protect the developing fetal brain. \n\n\n\nProfessor Matthews is committed to translating fundamental research to improve human health. In addition to leadership of the HeLTI-India trial and the Ontario Birth Study\, he co-founded the MAVAN program\, which followed neurocognitive development in children following adverse early experience. He has secured over $40M in research funding\, published 265 full papers and has received >300 invitations to present his work around the world. He was elected a Fellow of the Canadian Academy of Health Sciences (2019).  He has served as elected President of the Society for Reproductive Investigation. In 2015\, he co-founded DOHaD Canada and served as elected President (2018-23). \n\n\n\n\n\nSpeaker Information\n\n\n\n\n\n\n	\n		\n\n	\n		\n						\n							Stephen G. Matthews\, PhD\, FCAHS						\n					\n				Professor of Physiology\, Ob-Gyn and Medicine\, University of Toronto\n			\n			\n												\n	\n\n	\n\n\n\n\n\n\n\n\nOrganizers\n\n\n\n\n\n\nHarvard Chan NIEHS Center for Environmental Health\n\n\n\nDepartment of Environmental Health\n\n\n\n\n\n\n\n\n\n\n\n	\n		\n		\n			\n				\n					\n						Unleash your potential at Harvard Chan School.					\n					In addition to our degree programs\, we offer highly targeted executive and continuing education\, directed and taught by Harvard faculty. \n											\n																															\n									\n										Degree Programs									\n								\n																															\n									\n										How to Apply									\n								\n																															\n									\n										Executive and Continuing Education
URL:https://hsph.harvard.edu/events/discovery-to-intervention-the-healthy-life-trajectories-initiative-with-stephen-g-matthews-phd-fcahs/
LOCATION:HSPH\, Bldg. 1\, 1302 and Zoom
ATTACH;FMTTYPE=image/png:https://hsph.harvard.edu/wp-content/uploads/2026/03/Stephen-Matthews-Graphic-Simple-e1774449994188.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260515T130000
DTEND;TZID=America/New_York:20260515T150000
DTSTAMP:20260410T141359
CREATED:20260330T205708Z
LAST-MODIFIED:20260401T231458Z
UID:111360005918-1778850000-1778857200@hsph.harvard.edu
SUMMARY:Screening for Major Diseases — Does it help?
DESCRIPTION:Home / Events\n\n\n\n\n\n\nThe Global Flourishing Study\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTime \n\n\n\n\n\n\n\nEvent Type \n\n\n\n	From Around the School\, Lectures/Seminars/Forums\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Cutter Lectures on Preventive Medicine – 10th Symposium\n\n\n\nPart of the Cutter Lectures on Preventive Medicine series\, The 10th Cutter Symposium “Screening for Major Diseases—Does It Help?” will feature three separate lectures from expert speakers on the topic of screening for colorectal cancer\, prostate cancer\, and infectious diseases followed by a moderated Q&A segment with all the speakers. This symposium is open to the public & is virtual only. \n\n\n\nSchedule of talks: \n\n\n\n1:00PM  Introducing the Cutter SymposiumAlbert Hofman\, MD\, PhD1:05PMThe Power of Colorectal Cancer ScreeningHermann Brenner\, MD. MPHAbstract: Over 30 years ago\, in 1993\, a groundbreaking analysis of the US National Polyp Study was published\, which suggested that colonoscopic removal of colorectal polyps was associated with an 88% reduction of colorectal cancer incidence. Since then\, numerous observational studies and randomized trials have confirmed effectiveness of colorectal cancer screening\, even though most of them substantially underestimated screening effects for various reasons. Large heterogeneity in introduction of and adherence to screening programs across countries in the last three decades is mirrored in large heterogeneity of trends in colorectal cancer incidence and mortality. Modelling studies based on the accumulated evidence confirm that the vast majority of the approximately one million colorectal cancer deaths per year globally could be prevented by screening. 1:35PMControversies and Innovations in Screening for Prostate Cancer Lorelei Mucci\, ScD    Abstract: More than 1.6 million men across the globe are diagnosed with prostate cancer annually\, and it is the leading cause of cancer death in more than 50 countries. In randomized controlled trials\, screening with prostate specific antigen (PSA) has been shown to reduce cancer mortality over two decades. However\, PSA screening also has led to overdiagnosis of prostate cancers that have a low potential for metastasis and concomitant overtreatment of patients. What has ensued over the past two decades has been an active debate about the harms and benefits of screening\, guidelines that are often in conflict with one another\, and in the United States\, a substantial reduction in prostate cancer screening that is now tied to an uptake in incidence of metastatic prostate cancer. This talk will provide an overview of the history of PSA screening\, the evidence around risks and harms\, the controversies\, and recent innovations in approaches to accelerate a risk stratified approach to screening. 2:05PM       Diagnostics\, Screening\, and Surveillance in Pandemics Marc Lipsitch\, DPhilAbstract: This talk will describe challenges and opportunities for surveillance during large infectious disease events\, with lessons from COVID-19 and earlier pandemics. Active testing of population-based random samples provide numerous advantages over passive case detection in many situations\, while linked data on demographics\, severity\, and pathogen variant among other characteristics are far more valuable for decision making than the same data if unlinked. Better data can inform more efficient decisions about control measures that improve the ratio of disease control effectiveness to cost and disruption.2:35PMGeneral Discussion3:00PMClosing by Albert Hofman\n\n\n\nSpeakers will share their own perspectives; they do not speak for Harvard. \n\n\n\n\n\nSpeaker Information\n\n\n\n\n\n\n	\n		\n\n	\n		\n							Hermann Brenner\, MD\, MPH					\n				Professor of Epidemiology\, Heidelberg University\, Scientific Coordinator\, National Cancer Prevention Graduate School\, German Cancer Research Center (DKFZ)\, Heidelberg\, Germany\n			\n			\n												\n	\n\n\n\n	\n		\n						\n							Lorelei Mucci\, ScD						\n					\n				Professor of Epidemiology\, Head of the Cancer Epidemiology and Prevention Track\, Department of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n							\n					\n	\n\n\n\n	\n		\n						\n							Marc Lipsitch\, DPhil 						\n					\n				Berberian Professor and Senior Fellow\, Center for International Security and Cooperation Professor of Medicine\, and Professor of Biology\, Stanford University\, Adjunct Professor of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n												\n	\n\n\n\n	\n		\n						\n							Albert Hofman\, MD\, PhD						\n					\n				Stephen B. Kay Family Professor of Public Health and Clinical Epidemiology\, Chair\, Department of Epidemiology\, Harvard T.H. Chan School of Public Health\n			\n			\n												\n	\n\n	\n\n\n\n\n\n\n\n\nOrganizers\n\n\n\n\n\n\nDepartment of Epidemiology\n\n\n\n\n\n\n\n\n\n	\n		\n		\n			\n				\n					\n						Unleash your potential at Harvard Chan School.					\n					In addition to our degree programs\, we offer highly targeted executive and continuing education\, directed and taught by Harvard faculty. \n											\n																															\n									\n										Degree Programs									\n								\n																															\n									\n										How to Apply									\n								\n																															\n									\n										Executive and Continuing Education
URL:https://hsph.harvard.edu/epidemiology/events/screening-for-major-diseases-does-it-help/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hsph.harvard.edu/wp-content/uploads/2026/03/Event-page_Cutter-Symposium-May-15-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260518T083000
DTEND;TZID=America/New_York:20260518T170000
DTSTAMP:20260410T141359
CREATED:20260306T015716Z
LAST-MODIFIED:20260410T052816Z
UID:111360005897-1779093000-1779123600@hsph.harvard.edu
SUMMARY:HCMPH Center Annual Symposium
DESCRIPTION:Home / Events\n\n\n\n\n\n\nThe Global Flourishing Study\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTime \n\n\n\n\n\n\n\nEvent Type \n\n\n\n	From Around the School\, Lectures/Seminars/Forums\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWe are delighted to welcome everyone to the eighth annual Harvard Chan Microbiome in Public Health Center (HCMPH) symposium. As microbial community science expands across industry\, clinical research\, biotech\, and pharma\, this year’s theme – translating the microbiome – focuses on turning discovery into implementation. From the first approved live biotherapeutics to microbiome-informed cancer immunotherapy\, the field is already reshaping how we understand health and develop therapies.  \n\n\n\nThe symposium will highlight recent advances while looking ahead to future opportunities\, including microbial biochemistry in small-molecule drug development and engineering of microbial community members. As always\, we hope to be joined by an audience that is both topically and geographically diverse\, online and in person. The symposium program will include keynotes\, invited talks\, and selected presentations from poster submissions. We collect a nominal fee for in-person registration\, with virtual attendance available for free. Refreshments and a poster presentation are offered on-site\, and support for social media and interactive participation are provided for online attendees. \n\n\n\nFor more information on the event and the poster reception\, please visit this link. For questions: levesque@hsph.harvard.edu  \n\n\n\nRegistration\n\n\n\nIn-person registration is available: HEREVirtual registration continues to be free and is available here: virtual attendance only \n\n\n\nLocation:Harvard T.H. Chan School of Public HealthSnyder Auditorium – Kresge G1Poster Reception to be held in the Kresge CafeteriaVirtual attendance available via Zoom webinar (link emailed to you after completing registration for virtual attendance) \n\n\n\n\n\nSpeaker Information\n\n\n\n\n\n\n	\n		\n\n	\n		\n						\n							Eric Rubin\, MD\, PhD						\n					\n				Professor of Medicine\, Harvard Medical School\, Brigham and Women’s Hospital\, Editor-in-Chief of the New England Journal of Medicine with opening remarks\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							Michael Fischbach\, PhD						\n					\n				Liu (Liao) Family Professor\, Stanford University presents "Commensal vaccines”</em>\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							Laura Cox						\n					\n				Assistant Professor\, Brigham and Women’s Hospital presents “Dissecting strain-specific roles of the gut microbiome in neurologic diseases”</em>\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							Robert Britton\, PhD						\n					\n				Professor of Molecular Virology and Microbiology\, Baylor College of Medicine presents “The impact of the infant microbiome on brain development and cognition”</em>\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							Jose Clemente\, PhD						\n					\n				Associate Professor\, Icahn School of Medicine at Mount Sinai presents<em> “A tale of two trials: microbiome interventions in early life”</em>\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							Jean McGee\, MD\, PhD\, MS						\n					\n				Associate Professor\, Brigham and Women’s Hospital presents<br>“The gut feeling behind healthy skin: Expanding the role of the gut microbiome in dermatology”\n			\n			\n					\n	\n\n\n\n	\n		\n						\n							James Collins\, PhD						\n					\n				Termeer Professor of Medical Engineering and Science\, Massachusetts Institute of Technology presents “Microbiome-friendly medicine: engineering live therapeutics and AI-designed antibiotics”<br>\n			\n			\n					\n	\n\n	\n\n\n\n\n\n\n\n\nOrganizers\n\n\n\n\n\n\nDepartment of Biostatistics\n\n\n\n\n\n\n\n\n\n\n\n\n\n	\n		\n		\n			\n				\n					\n						Unleash your potential at Harvard Chan School.					\n					In addition to our degree programs\, we offer highly targeted executive and continuing education\, directed and taught by Harvard faculty. \n											\n																															\n									\n										Degree Programs									\n								\n																															\n									\n										How to Apply									\n								\n																															\n									\n										Executive and Continuing Education
URL:https://hsph.harvard.edu/biostatistics/events/hcmph-center-annual-symposium/
LOCATION:Kresge G1 & Online
ATTACH;FMTTYPE=image/jpeg:https://hsph.harvard.edu/wp-content/uploads/2026/03/Banner_1920-x-1080.jpg
END:VEVENT
END:VCALENDAR